Pharmaceutical Technology 2 Flashcards

(51 cards)

1
Q

Types of injections

A
  1. Intramuscular - into muscle
  2. Subcutaneous - into subcutaneous layer
  3. Intravenous - into vein
  4. Intradermal - into epidermis
  5. Intrathecal - into spinal cord
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

(Intrathecal injections) Drug delivered into ______ flows directly to the ____.

A

CSF
Brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How can drugs be administered for intrathecal injections?

A

a. Into reservoir (Ommaya)
b. Via lower back

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

CSF is a clear solution made up of?

A

99% water
1% protein, ions, neurotransmitters & glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

pH of CSF

A

~7.3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Volume of CSF

A

150mL, 430-530mL produced per day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CSF has variable ____, ____ and ___.

A

Viscosity
Flow rate
Pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Can intrathecal cross the BBB?

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Advantages of parenteral delivery 1

A

Bypasses hepatic 1st pass metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Advantages of parenteral delivery 2

A

Can control dosage
- Relatively low drug concentration and low toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Advantages of parenteral delivery 3

A

Direct access to brain (intrathecal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Advantages of parenteral delivery 4

A

Sustained release (intramuscular depot, intrathecal reservoirs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Advantages of parenteral delivery 5

A

Ideal for non-compliant, unconscious or dysphagic patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

From blood to brain, drug solution flows through ______.

A

Circulatory system
- Reticuloendothelial system (RES)
- Unless there is active targeting, drug will distribute everywhere

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Drugs must bypass ____ to access the brain.

A

BBB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

The blood brain barrier blocks uptake of __% of small molecular drug candidates.

A

98%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Types of transportation across BBB

A

Paracellular (tight junctions)
Transcellular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Examples of active efflux transporters

A

P-glycoprotein (P-gp), breast cancer resistance protein (BCRP), multi-drug resistance proteins (MRP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are active efflux transporters?

A

Removes drugs from organ (brain) into the lumen (blood)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Types of transporters in BBB

A
  1. Active efflux
  2. Carrier mediated (CMT)
  3. Receptor-mediated (RMT)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Modified Lipinski’s for CNS - MW

22
Q

Modified Lipinski’s for CNS - hydrogen bond donors

23
Q

Modified Lipinski’s for CNS - hydrogen bond acceptors

24
Q

Modified Lipinski’s for CNS m- LogP

25
Modified Lipinski's for CNS - ionisation state
Unionised
26
Delivery system - solutions
a. drug molecules b. proteins/peptides
27
Delivery system - suspensions
a. Nano/microemulsions b. Liposomes and other lipid-based self-assembled structures c. Nanoparticles
28
Common excipients of solutions for injection
1. Diluents 2. Buffer salts 3. Tonicity adjusters 4. Preservatives (minimal for intrathecal) 5. Stabilisers/co-solvent
29
pH consideration for parenteral delivery
Ideally 7.4 but wide range tolerated Intramuscular: 3-11 Subcutaneous: 3-6
30
Tonicity consideration for parenteral delivery
280-290 mOsm/L for large volume parenteral Hypertonic > hypotonic (can increase with tonicity adjuster)
31
Particle size consideration for parenteral delivery
No visible particles (more for IV than SC/IM)
32
Benzyl alcohol
Preservative
33
Ethanol
Solvent
34
Glycine
Solvent
35
PEG (mixed)
Solvent
36
Propylene glycol
Solvent
37
Glycerin/glycerol
Solvent/tonicity adjustment
38
Glycine
Solvent/tonicity adjustment
39
Thiomersal
Preservative
40
Mannitol
Tonicity adjusting agent / cryoprotectant
41
Sodium acetate, citrate, and phosphates (mixed), lactate
Buffer
42
Function of reservoir in infusions
Refilling
43
Function of catheter in infusions
Delivery
44
Function of pump in infusions
Automate dosing
45
Biocompatible material in infusion
Titanium
46
Haloperidol formulation
50mg/mL or 100mg/Ml injection
47
Site of administration of Haloperidol
IM into gluteal region
48
Interval between doses for Haloperidol
4 weeks
49
Half-life of Haloperidol
3 weeks
50
Baclofen route od adminitration
Intrathecal injection
51
Baclofen concentration in ____ is 100x higher than after _________.
CSF Oral administration